Literature DB >> 34866179

Both full length-cholesteryl ester transfer protein and exon 9-deleted cholesteryl ester transfer protein promote triacylglycerol storage in cultured hepatocytes.

Yan Liu1, Daniel Mihna1, Lahoucine Izem1, Richard E Morton1.   

Abstract

We previously reported that overexpression of full-length cholesteryl ester transfer protein (FL-CETP), but not its exon 9-deleted variant (∆E9-CETP), in an adipose cell line reduces their triacylglycerol (TAG) content. This provided mechanistic insight into several in vivo studies where FL-CETP levels are inversely correlated with adiposity. However, increased FL-CETP is also associated with elevated hepatic lipids, suggesting that the effect of CETP on cellular lipid metabolism may be tissue-specific. Here, we directly investigated the role of FL-CETP and ∆E9-CETP in hepatic lipid metabolism. FL- or ∆E9-CETP was overexpressed in HepG2-C3A by adenovirus transduction. Overexpression of either FL or ∆E9-CETP in hepatocytes increased cellular TAG mass by 25% but reduced TAG secretion. This cellular TAG was contained in larger and more numerous lipid droplets. Analysis of TAG synthetic and catabolic pathways showed that this elevated TAG content was due to increased incorporation of fatty acid into TAG (24%), and higher de novo synthesis of fatty acid (50%) and TAG from acetate (40%). siRNA knockdown of CETP had the opposite effect on TAG synthesis and lipogenesis, and decreased cellular TAG. This novel increase in cellular TAG by FL-CETP overexpression was reproduced in Caco-2 intestinal epithelial cells. We conclude that, unlike that seen in adipocyte cells, overexpression of either CETP isoform in lipoprotein-secreting cells promotes the accumulation of TAG. These data suggest that the in vivo correlation between CETP levels and hepatic steatosis can be explained, in part, by a direct effect of CETP on hepatocyte cellular metabolism.
© 2021 AOCS.

Entities:  

Keywords:  cellular lipid homeostasis; cholesteryl ester transfer protein; hepatocyte; isoforms; lipid metabolism; triacylglycerol

Mesh:

Substances:

Year:  2021        PMID: 34866179      PMCID: PMC9060302          DOI: 10.1002/lipd.12330

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.646


  52 in total

1.  Cholesteryl ester transfer protein biosynthesis and cellular cholesterol homeostasis are tightly interconnected.

Authors:  L Izem; R E Morton
Journal:  J Biol Chem       Date:  2001-05-14       Impact factor: 5.157

Review 2.  Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.

Authors:  Anke H E M Klerkx; Karim El Harchaoui; Wim A van der Steeg; S Matthijs Boekholdt; Erik S G Stroes; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-26       Impact factor: 8.311

Review 3.  Establishing the lipid droplet proteome: Mechanisms of lipid droplet protein targeting and degradation.

Authors:  Kirill Bersuker; James A Olzmann
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-06-13       Impact factor: 4.698

4.  A plasma inhibitor of triglyceride and cholesteryl ester transfer activities.

Authors:  R E Morton; D B Zilversmit
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

5.  Alternative splicing of human plasma cholesteryl ester transfer protein mRNA in Caco-2 cells and its modulation by oleic acid.

Authors:  M Dessí; C Motti; C Cortese; E Leonardis; C Giovannini; G Federici; F Piemonte
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

6.  Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.

Authors:  Changiz Taghibiglou; Stephen C Van Iderstine; Agnes Kulinski; Debbie Rudy; Khosrow Adeli
Journal:  Biochem Pharmacol       Date:  2002-02-01       Impact factor: 5.858

7.  The development of fatty liver is accelerated in transgenic mice expressing cynomolgus monkey cholesteryl ester transfer protein.

Authors:  W L Blake; R G Ulrich; K R Marotti; G W Melchior
Journal:  Biochem Biophys Res Commun       Date:  1994-12-15       Impact factor: 3.575

8.  Inhibition of the cellular secretion of cholesteryl ester transfer protein by a variant protein formed by alternative splicing of mRNA.

Authors:  E Quinet; T P Yang; C Marinos; A Tall
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

9.  Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA.

Authors:  X C Jiang; P Moulin; E Quinet; I J Goldberg; L K Yacoub; L B Agellon; D Compton; R Schnitzer-Polokoff; A R Tall
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

10.  Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis.

Authors:  Reza Fadaei; Hossein Poustchi; Reza Meshkani; Nariman Moradi; Taghi Golmohammadi; Shahin Merat
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.